Cytokinetics (CYTK) had the highest return between October 29, 2014 and March 6, 2015 by a mid-cap US stock, returning 117.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
Cytokinetics (CYTK) | 10/29/2014 - 3/6/2015 | 117.27% |
Celsius (CELH) | 10/29/2014 - 3/6/2015 | 108.87% |
Xenon Pharmaceuticals (XENE) | 10/29/2014 - 3/6/2015 | 91.82% |
Insperity (NSP) | 10/29/2014 - 3/6/2015 | 86.02% |
Tower Semiconductor (TSEM) | 10/29/2014 - 3/6/2015 | 84.6% |
PTC Therapeutics (PTCT) | 10/29/2014 - 3/6/2015 | 72.1% |
Magnite (MGNI) | 10/29/2014 - 3/6/2015 | 69.85% |
Frontline (FRO) | 10/29/2014 - 3/6/2015 | 67.12% |
Stonex (SNEX) | 10/29/2014 - 3/6/2015 | 63.5% |
Halozyme Therapeutics (HALO) | 10/29/2014 - 3/6/2015 | 62.57% |
MACOM Technology Solutions (MTSI) | 10/29/2014 - 3/6/2015 | 59.79% |
Qorvo (QRVO) | 10/29/2014 - 3/6/2015 | 59.21% |
Grupo Financiero Galicia SA ADR (GGAL) | 10/29/2014 - 3/6/2015 | 57.1% |
Qualys (QLYS) | 10/29/2014 - 3/6/2015 | 57.07% |
Columbia Sportswear (COLM) | 10/29/2014 - 3/6/2015 | 56.24% |
Ambarella (AMBA) | 10/29/2014 - 3/6/2015 | 54.97% |
Varonis Systems (VRNS) | 10/29/2014 - 3/6/2015 | 53.55% |
SkyWest (SKYW) | 10/29/2014 - 3/6/2015 | 53.3% |
Catalyst Pharmaceuticals (CPRX) | 10/29/2014 - 3/6/2015 | 52.75% |
Ionis Pharmaceuticals (IONS) | 10/29/2014 - 3/6/2015 | 51.48% |
Amkor Technology (AMKR) | 10/29/2014 - 3/6/2015 | 51.42% |
Dycom Industries (DY) | 10/29/2014 - 3/6/2015 | 51.22% |
TTM Technologies (TTMI) | 10/29/2014 - 3/6/2015 | 50.08% |
Cirrus Logic (CRUS) | 10/29/2014 - 3/6/2015 | 49.2% |
BBVA Banco Frances SA ADR (BBAR) | 10/29/2014 - 3/6/2015 | 46.28% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
